An Adrenocorticotropic Hormone-secreting Malignant Pancreatic Neuroendocrine Tumor

부신피질자극호르몬을 분비하는 췌장의 악성 신경내분비 종양 1예

  • Song, Eun-Mi (Department of Internal Medicine, Ewha Womans University School of Medicine) ;
  • Lee, Kyoung-Eun (Department of Internal Medicine, Ewha Womans University School of Medicine) ;
  • Jo, Jung-Youn (Department of Internal Medicine, Ewha Womans University School of Medicine) ;
  • Koo, Hea-Soo (Department of Pathology, Ewha Womans University School of Medicine) ;
  • Choi, Moon-Young (Department of Internal Medicine, Inje University College of Medicine) ;
  • Seong, Chu-Myong (Department of Internal Medicine, Ewha Womans University School of Medicine) ;
  • Lee, Soon-Nam (Department of Internal Medicine, Ewha Womans University School of Medicine)
  • 송은미 (이화여자대학교 의과대학 내과학교실) ;
  • 이경은 (이화여자대학교 의과대학 내과학교실) ;
  • 조정연 (이화여자대학교 의과대학 내과학교실) ;
  • 구혜수 (이화여자대학교 의과대학 병리학교실) ;
  • 최문영 (인제대학교 의과대학 내과학교실) ;
  • 성주명 (이화여자대학교 의과대학 내과학교실) ;
  • 이순남 (이화여자대학교 의과대학 내과학교실)
  • Published : 2011.02.01

Abstract

Pancreatic endocrine tumors are low-to-intermediate-grade neoplasms arising from the pancreatic islets that produce various hormones. These tumors account for a minority of pancreatic tumors and are generally considered functional if they are associated with a hormonal syndrome. Adrenocorticotropic hormone-secreting tumors (ACTHomas) are very rare and require special clinical consideration. Patients with ACTH-secreting tumors usually present with Cushing's syndrome, due to ectopic ACTH production. ACTHomas have a poor prognosis because of early metastasis and difficulty controlling corticosteroid production. We report a 62-year-old male with an ACTH-secreting metastatic pancreatic neuroendocrine tumor, who did not respond to somatostatin analogs and died.

췌장에서 기원한 부신피질자극호르몬을 분비하는 신경내분비 종양은 처음부터 간 전이 등이 흔한 악성 종양이다. 대개 Cushing 증후군의 임상양상을 보이며, 진단은 방사선학적 검사, 조직검사 및 혈청학적 검사를 기반으로 한다. 저자들은 somatostatin analogue 약물에 불응성이고, 급격한 임상적 악화를 보이면서 감염으로 사망하게 된, 다발성 간 전이를 동반한 부신피질자극호르몬을 분비하는 췌장의 신경 내분비 종양을 경험하였기에 보고하는 바이다.

Keywords

References

  1. Kaltsas GA, Besser GM, Grossman AB. The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev 2004;25:458-511. https://doi.org/10.1210/er.2003-0014
  2. Miehle K, Tannapfel A, Lamesch P, et al. Pancreatic neuroendocrine tumor with ectopic adrenocorticotropin production upon second recurrence. J Clin Endocrinol Metab 2004;89:3731-3736. https://doi.org/10.1210/jc.2003-032164
  3. Isidori AM, Lenzi A. Ectopic ACTH syndrome. Arq Bras Endocrinol Metabol 2007;51:1217-1225.
  4. Doppman JL, Nieman LK, Cutler GB Jr, et al. Adrenocorticotropic hormone-secreting islet cell tumors: are they always malignant? Radiology 1994;190:59-64. https://doi.org/10.1148/radiology.190.1.8259429
  5. Lee T, Karl M, Solorzano CC. Adrenocorticotropic hormone-secreting pancreatic islet cell carcinoma. J Am Coll Surg 2004;199:336-337. https://doi.org/10.1016/j.jamcollsurg.2004.02.031
  6. Terris B, Scoazec JY, Rubbia L, et al. Expression of vascular endothelial growth factor in digestive neuroendocrine tumours. Histopathology 1998;32:133-138. https://doi.org/10.1046/j.1365-2559.1998.00321.x
  7. Kulke MH. Neuroendocrine tumors: is there a standard treatment? Gastrointest Cancer Res 2008;2:152-153.
  8. Lokich J, Bothe A, O'Hara C, Federman M. Metastatic islet cell tumor with ACTH, gastrin, and glucagon secretion: clinical and pathologic studies with multiple therapies. Cancer 1987;59:2053-2058. https://doi.org/10.1002/1097-0142(19870615)59:12<2053::AID-CNCR2820591215>3.0.CO;2-H